v3.25.2
Income Taxes (Tables)
6 Months Ended
Mar. 31, 2025
Income Taxes [Abstract]  
Schedule of Company’s Continuing Operations in China and Consisted

Income taxes for the six months ended March 31, 2025 and 2024 are attributed to the Company’s continuing operations in China and consisted of:

 

   2025   2024 
Current income tax  $
-
   $
-
 
Deferred income tax expense (benefit)   (85,255)   24,805 
Total income tax expense (benefit)  $(85,255)  $24,805 
Schedule of Income Tax Expense

Income tax expense reconciliation are as follows:

 

   2025   2024 
Income before taxes  $65,532   $840,527 
PRC EIT tax rates   15%   15%
Tax at the PRC EIT tax rates  $9,830    126,079 
Rate differences in various jurisdictions   50,570    45,789 
Tax effect of R&D expenses deduction   (160,183)   (182,476)
Tax effect of non-taxable investment income and government grant        
-
 
Tax effect of non-deductible expenses   14,529    35,413 
Income tax expenses (benefits)  $(85,255)  $24,805 
Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of the Deferred Tax Asset

The tax effects of temporary differences that give rise to significant portions of the deferred tax asset at March 31, 2025 and September 30, 2024 are presented below:

 

   March 31,
2025
   September 30,
2024
 
Deferred tax assets:        
Allowance for expected credit losses  $196,301   $202,245 
Allowance for bad debt   29,187    47,416 
Loss carryforward   402,395    318,856 
DTA allowance   (10,209)   (17,643)
Total  $617,674   $550,874 
Schedule of Tax Payables

Taxes payable consist of the following:

 

   March 31,
2025
   September 30,
2024
 
Income tax payable  $2,869,955   $3,318,644 
VAT and tax payable (receivable)   (103,090)   325,521 
Total tax payable  $2,766,865   $3,644,165